Velmanase alfa-tycv: first FDA approval for non-CNS indications of alpha-mannosidosis

Published Date: 18 Feb 2023

Velmanase alfa-tycv: first FDA approval for non-CNS indications of alpha-mannosidosis

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

While most cancer screenings won't prolong lives, there are still good reasons to continue screening.

2.

High Fruit, Veggie Diet Tied to Early-Onset Lung Cancer?

3.

Cancer Diagnoses Slow to Recover From Effects of COVID Pandemic

4.

The pandemic had little impact on mental health symptoms.

5.

How breast tissue density affects your risk of breast cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot